| pembrolizumab based treatment |
| pembrolizumab alone | pembrolizumab plus SoC |
mGC or mGEJC - 1st line (L1) | | |
mGC or mGEJC - L1 - all population | | |
mGC or mGEJC - L1 - HER2 neg/PDL1 positive 2 | | |
mGC or mGEJC - L1 - HER2 negative 1 | | |
mGC or mGEJC - L1 - HER2 positive | | |
mGC or mGEJC - L1 - PDL1 positive 4 | | |